Publikation

Association of perioperative adverse events with subsequent therapy and overall survival in patients with WHO grade III and IV gliomas.

Wissenschaftlicher Artikel/Review - 28.09.2022

Bereiche
PubMed
DOI
Kontakt

Zitation
Weber L, Padevit L, Müller T, Velz J, Vasella F, Voglis S, Gramatzki D, Weller M, Regli L, Sarnthein J, Neidert M. Association of perioperative adverse events with subsequent therapy and overall survival in patients with WHO grade III and IV gliomas. Front Oncol 2022; 12:959072.
Art
Wissenschaftlicher Artikel/Review (Englisch)
Zeitschrift
Front Oncol 2022; 12
Veröffentlichungsdatum
28.09.2022
ISSN (Druck)
2234-943X
Seiten
959072
Kurzbeschreibung/Zielsetzung

Maximum safe resection followed by chemoradiotherapy as current standard of care for WHO grade III and IV gliomas can be influenced by the occurrence of perioperative adverse events (AE). The aim of this study was to determine the association of AE with the timing and choice of subsequent treatments as well as with overall survival (OS).